APO Research
Talk to an analyst

APO RESEARCH · REPORT

Haemophilus Influenzae Type B Injection Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Haemophilus Influenzae Type B Injection Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025199 pages

Choose your research edition.

Industry ResearchHaemophilus Influenzae Type B Injection Vaccine Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Haemophilus Influenzae Type B Injection Vaccine Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Haemophilus Influenzae Type B Injection Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Haemophilus Influenzae Type B Injection Vaccine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Haemophilus Influenzae Type B Injection Vaccine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Haemophilus Influenzae Type B Injection Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Haemophilus Influenzae Type B Injection Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Haemophilus Influenzae Type B Injection Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Haemophilus Influenzae Type B Injection Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Haemophilus Influenzae Type B Injection Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Haemophilus Influenzae Type B Injection Vaccine include Bharat Biotech, Biokangtai, Glaxosmithkline, Olymvax, Sanofi Pasteur, Walvax Biotechnology, Beijing Minhai Biotechnology Co., Ltd, Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd and Chengdu Oulin Biotechnology Co., Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Haemophilus Influenzae Type B Injection Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Haemophilus Influenzae Type B Injection Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Haemophilus Influenzae Type B Injection Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Haemophilus Influenzae Type B Injection Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Haemophilus Influenzae Type B Injection Vaccine Segment by Company

Bharat Biotech

Biokangtai

Glaxosmithkline

Olymvax

Sanofi Pasteur

Walvax Biotechnology

Beijing Minhai Biotechnology Co., Ltd

Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd

Chengdu Oulin Biotechnology Co., Ltd

Chengdu Institute of Biological Products Co., Ltd

Lanzhou Institute of Biological Products Co., Ltd

Yuxi Watson Biotechnology Co., Ltd

Haemophilus Influenzae Type B Injection Vaccine Segment by Type

Lyophilized

Non-lyophilized

Haemophilus Influenzae Type B Injection Vaccine Segment by Application

Hospital

Clinic

Haemophilus Influenzae Type B Injection Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Haemophilus Influenzae Type B Injection Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Haemophilus Influenzae Type B Injection Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Haemophilus Influenzae Type B Injection Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Haemophilus Influenzae Type B Injection Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Haemophilus Influenzae Type B Injection Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Haemophilus Influenzae Type B Injection Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Haemophilus Influenzae Type B Injection Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Haemophilus Influenzae Type B Injection Vaccine Industry Trends Table 2. Haemophilus Influenzae Type B Injection Vaccine Industry Drivers Table 3. Haemophilus Influenzae Type B Injection Vaccine Industry Opportunities and Challenges Table 4. Haemophilus Influenzae Type B Injection Vaccine Industry Restraints Table 5. Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Manufacturers Table 9. Global Haemophilus Influenzae Type B Injection Vaccine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Haemophilus Influenzae Type B Injection Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Haemophilus Influenzae Type B Injection Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Haemophilus Influenzae Type B Injection Vaccine Manufacturers, Product Type & Application Table 13. Global Haemophilus Influenzae Type B Injection Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Haemophilus Influenzae Type B Injection Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Lyophilized Table 17. Major Manufacturers of Non-lyophilized Table 18. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021-2026) & (K Units) Table 20. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2027-2032) & (K Units) Table 21. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2021-2026) & (K Units) Table 25. Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2027-2032) & (K Units) Table 26. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021-2026) & (K Units) Table 32. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2027-2032) & (K Units) Table 33. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Application (2021-2026) Table 34. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Application (2027-2032) Table 35. Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2021-2026) & (K Units) Table 37. Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2027-2032) & (K Units) Table 38. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Application (2021-2026) Table 39. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Application (2027-2032) Table 40. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region (2021-2026) & (K Units) Table 42. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Region (2021-2026) Table 43. Global Haemophilus Influenzae Type B Injection Vaccine Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Haemophilus Influenzae Type B Injection Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Haemophilus Influenzae Type B Injection Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2026) & (K Units) Table 47. North America Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2027-2032) & (K Units) Table 48. Europe Haemophilus Influenzae Type B Injection Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2026) & (K Units) Table 50. Europe Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Haemophilus Influenzae Type B Injection Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2027-2032) & (K Units) Table 57. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Region (2021-2026) Table 61. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Region (2027-2032) Table 62. Bharat Biotech Company Information Table 63. Bharat Biotech Business Overview Table 64. Bharat Biotech Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Bharat Biotech Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 66. Bharat Biotech Recent Development Table 67. Biokangtai Company Information Table 68. Biokangtai Business Overview Table 69. Biokangtai Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Biokangtai Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 71. Biokangtai Recent Development Table 72. Glaxosmithkline Company Information Table 73. Glaxosmithkline Business Overview Table 74. Glaxosmithkline Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Glaxosmithkline Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 76. Glaxosmithkline Recent Development Table 77. Olymvax Company Information Table 78. Olymvax Business Overview Table 79. Olymvax Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Olymvax Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 81. Olymvax Recent Development Table 82. Sanofi Pasteur Company Information Table 83. Sanofi Pasteur Business Overview Table 84. Sanofi Pasteur Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Sanofi Pasteur Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 86. Sanofi Pasteur Recent Development Table 87. Walvax Biotechnology Company Information Table 88. Walvax Biotechnology Business Overview Table 89. Walvax Biotechnology Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Walvax Biotechnology Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 91. Walvax Biotechnology Recent Development Table 92. Beijing Minhai Biotechnology Co., Ltd Company Information Table 93. Beijing Minhai Biotechnology Co., Ltd Business Overview Table 94. Beijing Minhai Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Beijing Minhai Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 96. Beijing Minhai Biotechnology Co., Ltd Recent Development Table 97. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Company Information Table 98. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Business Overview Table 99. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 101. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Recent Development Table 102. Chengdu Oulin Biotechnology Co., Ltd Company Information Table 103. Chengdu Oulin Biotechnology Co., Ltd Business Overview Table 104. Chengdu Oulin Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Chengdu Oulin Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 106. Chengdu Oulin Biotechnology Co., Ltd Recent Development Table 107. Chengdu Institute of Biological Products Co., Ltd Company Information Table 108. Chengdu Institute of Biological Products Co., Ltd Business Overview Table 109. Chengdu Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Chengdu Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 111. Chengdu Institute of Biological Products Co., Ltd Recent Development Table 112. Lanzhou Institute of Biological Products Co., Ltd Company Information Table 113. Lanzhou Institute of Biological Products Co., Ltd Business Overview Table 114. Lanzhou Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Lanzhou Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 116. Lanzhou Institute of Biological Products Co., Ltd Recent Development Table 117. Yuxi Watson Biotechnology Co., Ltd Company Information Table 118. Yuxi Watson Biotechnology Co., Ltd Business Overview Table 119. Yuxi Watson Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Yuxi Watson Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 121. Yuxi Watson Biotechnology Co., Ltd Recent Development Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Haemophilus Influenzae Type B Injection Vaccine Distributors List Table 125. Haemophilus Influenzae Type B Injection Vaccine Customers List Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Haemophilus Influenzae Type B Injection Vaccine Product Image Figure 2. Global Haemophilus Influenzae Type B Injection Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Haemophilus Influenzae Type B Injection Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Haemophilus Influenzae Type B Injection Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Haemophilus Influenzae Type B Injection Vaccine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Haemophilus Influenzae Type B Injection Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Lyophilized Image Figure 9. Non-lyophilized Image Figure 10. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Application (2021-2032) Figure 21. Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Application (2021-2032) Figure 24. North America Haemophilus Influenzae Type B Injection Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Country (2021-2032) Figure 26. U.S. Haemophilus Influenzae Type B Injection Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Haemophilus Influenzae Type B Injection Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Haemophilus Influenzae Type B Injection Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Haemophilus Influenzae Type B Injection Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Country (2021-2032) Figure 31. Germany Haemophilus Influenzae Type B Injection Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Haemophilus Influenzae Type B Injection Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Haemophilus Influenzae Type B Injection Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Haemophilus Influenzae Type B Injection Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Haemophilus Influenzae Type B Injection Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Haemophilus Influenzae Type B Injection Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Country (2021-2032) Figure 38. China Haemophilus Influenzae Type B Injection Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Haemophilus Influenzae Type B Injection Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Haemophilus Influenzae Type B Injection Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Haemophilus Influenzae Type B Injection Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Haemophilus Influenzae Type B Injection Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Haemophilus Influenzae Type B Injection Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Country (2021-2032) Figure 46. Brazil Haemophilus Influenzae Type B Injection Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Haemophilus Influenzae Type B Injection Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Haemophilus Influenzae Type B Injection Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Haemophilus Influenzae Type B Injection Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Haemophilus Influenzae Type B Injection Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Haemophilus Influenzae Type B Injection Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Haemophilus Influenzae Type B Injection Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Haemophilus Influenzae Type B Injection Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Haemophilus Influenzae Type B Injection Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032) & (US$ Million) Figure 57. North America Haemophilus Influenzae Type B Injection Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Haemophilus Influenzae Type B Injection Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Haemophilus Influenzae Type B Injection Vaccine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Haemophilus Influenzae Type B Injection Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Lyophilized
  • Non-lyophilized
Applications
  • Hospital
  • Clinic
Companies covered
  • Bharat Biotech
  • Biokangtai
  • Glaxosmithkline
  • Olymvax
  • Sanofi Pasteur
  • Walvax Biotechnology
  • Beijing Minhai Biotechnology Co., Ltd
  • Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
  • Chengdu Oulin Biotechnology Co., Ltd
  • Chengdu Institute of Biological Products Co., Ltd
  • Lanzhou Institute of Biological Products Co., Ltd
  • Yuxi Watson Biotechnology Co., Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Haemophilus Influenzae Type B Injection Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Haemophilus Influenzae Type B Injection Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Haemophilus Influenzae Type B Injection Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Haemophilus Influenzae Type B Injection Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Haemophilus Influenzae Type B Injection Vaccine Market Dynamics
  1. 2.1 Haemophilus Influenzae Type B Injection Vaccine Industry Trends
  2. 2.2 Haemophilus Influenzae Type B Injection Vaccine Industry Drivers
  3. 2.3 Haemophilus Influenzae Type B Injection Vaccine Industry Opportunities and Challenges
  4. 2.4 Haemophilus Influenzae Type B Injection Vaccine Industry Restraints
3 Haemophilus Influenzae Type B Injection Vaccine Market by Manufacturers
  1. 3.1 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Haemophilus Influenzae Type B Injection Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Haemophilus Influenzae Type B Injection Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Haemophilus Influenzae Type B Injection Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Haemophilus Influenzae Type B Injection Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Haemophilus Influenzae Type B Injection Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Haemophilus Influenzae Type B Injection Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Haemophilus Influenzae Type B Injection Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Haemophilus Influenzae Type B Injection Vaccine Tier 1, Tier 2, and Tier 3
4 Haemophilus Influenzae Type B Injection Vaccine Market by Type
  1. 4.1 Haemophilus Influenzae Type B Injection Vaccine Type Introduction
  2. 4.1.1 Lyophilized
  3. 4.1.2 Non-lyophilized
  4. 4.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Type
  5. 4.2.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Type
  9. 4.3.1 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Type (2021-2032)
5 Haemophilus Influenzae Type B Injection Vaccine Market by Application
  1. 5.1 Haemophilus Influenzae Type B Injection Vaccine Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Application
  5. 5.2.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Application
  9. 5.3.1 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Application (2021-2032)
6 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region
  1. 6.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Haemophilus Influenzae Type B Injection Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Haemophilus Influenzae Type B Injection Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Haemophilus Influenzae Type B Injection Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Region
  1. 7.1 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Region
  2. 7.1.1 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Haemophilus Influenzae Type B Injection Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Haemophilus Influenzae Type B Injection Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Bharat Biotech
  2. 8.1.1 Bharat Biotech Company Information
  3. 8.1.2 Bharat Biotech Business Overview
  4. 8.1.3 Bharat Biotech Haemophilus Influenzae Type B Injection Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bharat Biotech Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  6. 8.1.5 Bharat Biotech Recent Developments
  7. 8.2 Biokangtai
  8. 8.2.1 Biokangtai Company Information
  9. 8.2.2 Biokangtai Business Overview
  10. 8.2.3 Biokangtai Haemophilus Influenzae Type B Injection Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Biokangtai Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  12. 8.2.5 Biokangtai Recent Developments
  13. 8.3 Glaxosmithkline
  14. 8.3.1 Glaxosmithkline Company Information
  15. 8.3.2 Glaxosmithkline Business Overview
  16. 8.3.3 Glaxosmithkline Haemophilus Influenzae Type B Injection Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Glaxosmithkline Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  18. 8.3.5 Glaxosmithkline Recent Developments
  19. 8.4 Olymvax
  20. 8.4.1 Olymvax Company Information
  21. 8.4.2 Olymvax Business Overview
  22. 8.4.3 Olymvax Haemophilus Influenzae Type B Injection Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Olymvax Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  24. 8.4.5 Olymvax Recent Developments
  25. 8.5 Sanofi Pasteur
  26. 8.5.1 Sanofi Pasteur Company Information
  27. 8.5.2 Sanofi Pasteur Business Overview
  28. 8.5.3 Sanofi Pasteur Haemophilus Influenzae Type B Injection Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sanofi Pasteur Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  30. 8.5.5 Sanofi Pasteur Recent Developments
  31. 8.6 Walvax Biotechnology
  32. 8.6.1 Walvax Biotechnology Company Information
  33. 8.6.2 Walvax Biotechnology Business Overview
  34. 8.6.3 Walvax Biotechnology Haemophilus Influenzae Type B Injection Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Walvax Biotechnology Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  36. 8.6.5 Walvax Biotechnology Recent Developments
  37. 8.7 Beijing Minhai Biotechnology Co., Ltd
  38. 8.7.1 Beijing Minhai Biotechnology Co., Ltd Company Information
  39. 8.7.2 Beijing Minhai Biotechnology Co., Ltd Business Overview
  40. 8.7.3 Beijing Minhai Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Beijing Minhai Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  42. 8.7.5 Beijing Minhai Biotechnology Co., Ltd Recent Developments
  43. 8.8 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
  44. 8.8.1 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Company Information
  45. 8.8.2 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Business Overview
  46. 8.8.3 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  48. 8.8.5 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Recent Developments
  49. 8.9 Chengdu Oulin Biotechnology Co., Ltd
  50. 8.9.1 Chengdu Oulin Biotechnology Co., Ltd Company Information
  51. 8.9.2 Chengdu Oulin Biotechnology Co., Ltd Business Overview
  52. 8.9.3 Chengdu Oulin Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Chengdu Oulin Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  54. 8.9.5 Chengdu Oulin Biotechnology Co., Ltd Recent Developments
  55. 8.10 Chengdu Institute of Biological Products Co., Ltd
  56. 8.10.1 Chengdu Institute of Biological Products Co., Ltd Company Information
  57. 8.10.2 Chengdu Institute of Biological Products Co., Ltd Business Overview
  58. 8.10.3 Chengdu Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Chengdu Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  60. 8.10.5 Chengdu Institute of Biological Products Co., Ltd Recent Developments
  61. 8.11 Lanzhou Institute of Biological Products Co., Ltd
  62. 8.11.1 Lanzhou Institute of Biological Products Co., Ltd Company Information
  63. 8.11.2 Lanzhou Institute of Biological Products Co., Ltd Business Overview
  64. 8.11.3 Lanzhou Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Lanzhou Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  66. 8.11.5 Lanzhou Institute of Biological Products Co., Ltd Recent Developments
  67. 8.12 Yuxi Watson Biotechnology Co., Ltd
  68. 8.12.1 Yuxi Watson Biotechnology Co., Ltd Company Information
  69. 8.12.2 Yuxi Watson Biotechnology Co., Ltd Business Overview
  70. 8.12.3 Yuxi Watson Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Yuxi Watson Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  72. 8.12.5 Yuxi Watson Biotechnology Co., Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Haemophilus Influenzae Type B Injection Vaccine Value Chain Analysis
  2. 9.1.1 Haemophilus Influenzae Type B Injection Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Haemophilus Influenzae Type B Injection Vaccine Production Mode & Process
  6. 9.2 Haemophilus Influenzae Type B Injection Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Haemophilus Influenzae Type B Injection Vaccine Distributors
  9. 9.2.3 Haemophilus Influenzae Type B Injection Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst